Advertisement

The Bone Scan in Metabolic Bone Disease

  • I. Fogelman

Abstract

Skeletal uptake of 99mTc-labelled diphosphonate depends primarily upon osteoblastic activity and, to a lesser extent, skeletal vascularity (Fogelman 1980). A bone scan image therefore presents a functional display of total skeletal metabolism and as such has a potentially valuable role to play in the assessment of patients with metabolic bone disorders. However, the bone scan appearances in metabolic bone disease are often non-specific, and their recognition depends upon a subjective impression of increased tracer uptake throughout the whole skeleton (Fogelman and Citrin 1981). This may be particularly difficult to detect when dealing with mild disease. It is the presence of focal lesions, as in metastatic disease, that makes a bone scan appear obviously abnormal. While focal lesions are easily identified, slightly increased tracer uptake throughout the whole skeleton may be virtually impossible to detect by visual inspection alone.

Keywords

Primary Hyperparathyroidism Metabolic Bone Disease Parathyroid Carcinoma Renal Osteodystrophy Myositis Ossificans 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alberts C, Van der Schoot JB, Busemann-Sokole E (1981) Bone scintigraphy and densitometry in symptomatic haemodialysis bone disease. Eur J Nucl Med 6: 505–509PubMedGoogle Scholar
  2. Ali A, Tetalman MR, Fordham EW et al. (1980) Distribution of hypertrophic pulmonary osteoarthropathy. Am J Radiol 134: 771–780Google Scholar
  3. Briancon D, Meunier PJ (1981) Treatment of osteoporosis with fluoride, calcium and vitamin D. Orthop Clin North Am 12: 629–648PubMedGoogle Scholar
  4. Cavalli PL, Camuzzini GF, Ghezzi P, Palanca R, Rovere A, Tortore P (1976) Total body gammagraphy in uraemic patients. Minerva Nefrol 23: 142–148PubMedGoogle Scholar
  5. de Graaf P, Schicht IM, Pauwels EK, te Velde J, de Graeff J (1978) Bone scintigraphy in renal osteodystrophy. J Nucl Med 19: 1289–1296PubMedGoogle Scholar
  6. de Graaf P, Schicht IM, Pauwels EKJ, Souverijn JHM, de Graeff J (1979) Bone scintigraphy in uremic pulmonary calcification. J Nucl Med 20: 201–206Google Scholar
  7. de Graaf P, Pauwels EKJ, Vos PH, Schicht IM, te Velde J, de Graeff J (1984) Observations on computerized quantitative bone scintigraphy in renal osteodystrophy. Eur J Nucl Med 9: 419–425PubMedCrossRefGoogle Scholar
  8. Devacaanthan K, Yap AU, Chayes Z, Stein RM (1976) Pulmonary calcification in chronic renal failure; use of diphosphonate scintiscan as a diagnostic tool. Clin Nephrol 6: 488–491PubMedGoogle Scholar
  9. Duraler F, Vulpetti AT, Guise ER, Levin NM (1977) 18F -scintigraphy in the early diagnosis of osteonecrosis of the femoral head in chronic haemodialysis and transplantation. Clin Nephrol 8: 349–353Google Scholar
  10. Evens RG, Ashburn W, Bartter FC (1969) Strontium 85 scanning of a “brown tumour” in a patient with parathyroid carcinoma. Br J Radiol 42: 224–225PubMedCrossRefGoogle Scholar
  11. Fogelman I (1980) Skeletal uptake of diphosphonate: a review. Eur J Nucl Med 3: 473–476Google Scholar
  12. Fogelman I, Boyle IT (1980) Bone scanning in clinical practice. Scott Med J 25: 45–49PubMedGoogle Scholar
  13. Fogelman I, Carr D (1980) A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease. Clin Radiol 31: 321–326PubMedCrossRefGoogle Scholar
  14. Fogelman I, Citrin DL (1981) Bone scanning in metabolic bone disease: a review. Appl Radiol 10: 158–166Google Scholar
  15. Fogelman I, McKillop JH, Greig WR, Boyle IT (1977a) Pseudofracture of the ribs detected by bone scanning. J Nucl Med 18: 1236–1237PubMedGoogle Scholar
  16. Fogelman I, McKillop JH, Cowden EA, Fine A, Boyce B, Boyle ET, Greig WR (1977b) Bone scan findings in hypervitaminosis D: case report. J Nucl Med 18: 1205–1207PubMedGoogle Scholar
  17. Fogelman I, McKillop JH, Bessent RG, Boyle IT, Turner JG, Greig WR (1978a) The role of bone scanning in osteomalacia. J Nucl Med 19: 245–248PubMedGoogle Scholar
  18. Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR (1978b) The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 19: 270–275PubMedGoogle Scholar
  19. Fogelman I, Citrin DL, Turner JG, Hay ID, Bessent RG, Boyle IT (1979) Semi-quantitative interpretation of the bone scan in metabolic bone disease. Eur J Nucl Med 4: 287–289PubMedCrossRefGoogle Scholar
  20. Fogelman I, Bessent RG, Beastall G, Boyle IT (1980a) Estimation of skeletal involvement in primary hyperparathyroidism. Ann Intern Med 92: 65–67PubMedGoogle Scholar
  21. Fogelman I, Hay ED, Turner JG, Citrin DL, Greig WR (1980b) Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone values. Br J Radiol 53: 874–877PubMedCrossRefGoogle Scholar
  22. Fogelman I, McKillop JH, Gray HW (1983) The ‘hot’ patella sign—is it of any clinical significance? J Nucl Med 24: 312–315PubMedGoogle Scholar
  23. Francis MD, Horn PA, Tofe AJ (1981) Controversial mechanism of technetium-99m deposition on bone. J Nucl Med 22: 72 (abstract)Google Scholar
  24. Front D, Hardaoff R, Levy J, Benderly A (1978) Bone scintigraphy in scurvy. J Nucl Med 19: 916–917PubMedGoogle Scholar
  25. Frost HM (1963) Bone remodelling dynamics. Thomas, Springfield, IllGoogle Scholar
  26. Hall FM, Goldberg RP, Davies JAK, Fainsinger MH (1980) Scintigraphic assessment of bone islands. Radiology 135: 737–742PubMedGoogle Scholar
  27. Heaney RP (1963) Evaluation and interpretation of calciumkinetic data in man. Clin Orthop 31: 153–183PubMedGoogle Scholar
  28. Kipper MS, Alazraki NP, Feiglin DH (1982) The “hot” patella. Clin Nucl Med 7: 28–32PubMedCrossRefGoogle Scholar
  29. Kukar N, Sy WM (1981) Selected endocrine disorders. In: Sy WM (ed) Gamma images in benign and metabolic bone diseases, vol H. CRC Press, Boca Raton, Fla, pp 1–21Google Scholar
  30. Leicht E, Berberich R, Lauffenburger T, Haas HG (1979) Tumoral calcinosis: accumulation of bone-seeking tracers in the calcium deposits. Eur J Nucl Med 4: 419–421PubMedCrossRefGoogle Scholar
  31. Levine SB, Haines JE, Larson SM, Andrews TM (1977) Reduced skeletal localization of 99m-Tc-diphosphonate in two cases of severe osteoporosis. Clin Nucl Med 2: 318–321CrossRefGoogle Scholar
  32. Lien JW, Wiegmann T, Rosenthall L, Kaye M (1976) Abnormal 99mtechnetium-tin-pyrophosphate bone scans in chronic renal failure. Clin Nephrol 6: 509–512PubMedGoogle Scholar
  33. Matin P (1979) The appearance of bone scans following fractures, including immediate and long-term studies. J Nucl Med 20: 1227–1231PubMedGoogle Scholar
  34. Nordin BEC, Horsman A, Aaron J (1976) Diagnostic procedures. In: Nordin BEC (ed) Calcium, phosphate and magnesium metabolism. Churchill Livingstone, Edinburgh, pp 469–524Google Scholar
  35. O’Duffy JD, Wahner HW, O’Fallon WM, Johnson KA, Muhs J, Riggs BL (1986). Mechanism of acute lower extremity pain syndrome in fluoride-treated osteoporotic patients. Am J Med 80: 561–566PubMedCrossRefGoogle Scholar
  36. Olgaard K, Heerfordt J, Madsen S (1976) Scintigraphic skeletal changes in uraemic patients on regular haemodialysis. Nephron 17: 325–334PubMedCrossRefGoogle Scholar
  37. Olgaard K, Madsen S, Heerfordt J, Hammer M, Jensen H (1979) Scintigraphic skeletal changes in non-dialyzed patients with advanced renal failure. Clin Nephrol 12: 273–278PubMedGoogle Scholar
  38. Park H-M, Lambertus J (1977) Skeletal and reticuloendothelial imaging in osteopetrosis: case report. J Nucl Med 18: 1091–1095PubMedGoogle Scholar
  39. Parkinson IS, Ward MK, Kerr DNS (1981) Dialysis encephalopathy, bone disease and anaemia: the aluminium intoxication syndrome during regular haemodialysis. J Clin Pathol 34: 1285–1294PubMedCrossRefGoogle Scholar
  40. Riggs BL, Seeman E, Hodgson SF, Taves DR, O’Fallon WM (1982) Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. New Engl J Med 306: 446–450PubMedCrossRefGoogle Scholar
  41. Rosenbaum RC, Frieri M, Metcalfe DD (1984) Patterns of skeletal scintigraphy and their relationship to plasma and urinary histamine levels in systemic mastocytosis. J Nucl Med 25: 859–864PubMedGoogle Scholar
  42. Rosenthall L, Kaye M (1976) Observations on the mechanisms of 99mTc-labelled phosphate complex uptake in metabolic bone disease. Semin Nucl Med 6: 59–67PubMedCrossRefGoogle Scholar
  43. Schulz EE, Libanati CR, Farley SM, Kirk GA, Baylink DJ (1984) Skeletal scintigraphic changes in osteoporosis treated with sodium fluoride: concise communication. J Nucl Med 25: 651–655PubMedGoogle Scholar
  44. Singh BN, Kesala BA, Mehta SP, Quinn JL (1977) Osteomalacia on bone scan simulating skeletal metastases. Clin Nucl Med 2: 181–183CrossRefGoogle Scholar
  45. Suzuki Y, Hisada K, Takeda M (1974) Demonstration of myositis ossificans by 99mTc pyrophosphate bone scanning. Radiology 111: 663–664PubMedGoogle Scholar
  46. Sy WM (1974) Bone scan in primary hyperparathyroidism. J Nucl Med 15: 1089–1091PubMedGoogle Scholar
  47. Sy WM (ed) (1981) Osteoporosis. In: Gamma images in benign and metabolic bone diseases. CRC Press, Boca Raton, Fla, pp 223–239Google Scholar
  48. Sy WM, Mittal AK (1975) Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy. Br J Radiol 48: 878–884PubMedCrossRefGoogle Scholar
  49. Sy WM, Smith AJ (1981) Chronic renal dialysis. In: Sy WM (ed) Gamma images in benign and metabolic bone diseases. CRC Press, Boca Raton, Fla, pp 151–186Google Scholar
  50. Sy WM, Bonventure MV, Camera A (1976) Bone scan in mastocytosis: case report. J Nucl Med 17: 699–701PubMedGoogle Scholar
  51. Sy WM, Mottola O, Lao RS, Smith A, Freund HR (1977) Unusual bone images in hyperparathyroidism. Br J Radiol 50: 740–744PubMedCrossRefGoogle Scholar
  52. Tyler JL, Derbekyan V, Lisbona R (1984) Early diagnosis of myositis ossificans with Tc-99m diphosphonate imaging. Clin Nucl Med 9: 256–258PubMedCrossRefGoogle Scholar
  53. Vanherweghem JL, Schoutens A, Bergmann P, Stolear J-C, Abramowicz D, Dhaene M, Smeyers J, Verbeelen D, Fuss M, Kinneart P (1984) Usefulness of 99mTc-pyrophosphate bone scintigraphy in aluminium bone disease. Trace Elements in Medicine 1: 80–83Google Scholar
  54. Whyte MP, Murphy WA, Siegel BA (1978) 99mTc-pyrophosphate bone imaging in osteopoikilosis, osteopathia striata and melorheostosis. Radiology 127: 439–443PubMedGoogle Scholar
  55. Wiegmann T, Rosenthall L, Kaye M (1977) Technetium 99m- pyrophosphate bone scans in hyperparathyroidism. J Nucl Med 18: 231–235PubMedGoogle Scholar
  56. Wilkins WE, Chalmers A, Sanerkin NG, Rowe MJ (1983) Osteomalacia in the elderly: the value of radio-isotope bone scanning in patients with equivocal biochemistry. Age Ageing 12: 195–200PubMedCrossRefGoogle Scholar
  57. Wilson MA (1981) The effect of age on the quality of bone scans using technetium-99m pyrophosphate. Radiology 139: 703–705PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • I. Fogelman

There are no affiliations available

Personalised recommendations